Speed Key For Antiviral To Work: Cowling
"); jQuery("#212 h3").html("

"); });
2022-03-16 HKT 09:09
A leading epidemiologist said on Wednesday that the SAR must ensure that a groundbreaking anti-viral treatment gets to Covid-19 patients as quickly as possible if it's to have the maximum effect in reducing hospital admissions and deaths.
The Hospital Authority is rolling out Paxlovid for vulnerable Covid patients from Wednesday, with those showing mild symptoms given the pill at designated clinics, care homes and public hospitals.
Speaking on RTHK's Hong Kong Today programme, Benjamin Cowling from the University of Hong Kong's School of Public Health, said the treatment could substantially reduce severe cases.
"It looks very promising from the clinical trials," he told RTHK's Vicky Wong. "If it's given early, as early as possible, there's an indication that it could substantially reduce the risk of severe disease."
"Now if it's given to people after a few days of illness, after a week of illness, and they go to the hospital in a serious condition already, it won't work so well. It really has to be given very, very early."
The SAR has purchased an undisclosed number of Paxlovid pills from its manufacturer, Pfizer. It's also bought supplies of another antiviral, Molnupiravir, which has shown lower effectiveness in trials but which may be suitable for patients who can't receive Paxlovid, such as those with kidney problems.
Cowling said it's not time to relax social distancing measures despite falling case numbers.
"Thankfully the case numbers are coming down. They're coming down slowly, but I think they will continue to come down. We know there've already been a lot of infections. There's a large number of confirmed cases and, of course, many more infections that were not confirmed," he said.
"So we know that this epidemic is in decline, the numbers will continue to go down to a low level but not quite yet, so I don't think it's a good time yet to relax the measures that we have in place. Let's wait until the numbers get a little bit lower."
Hong Kong reported 27,765 new cases on Tuesday.
Alibaba Invests Over US$50 Billion To Drive AI And Cloud Expansion By 2028
Alibaba Group (9988.HK) revealed plans to invest over 380 billion yuan (US$52.44 billion) into its cloud computing and ... Read more
SFC IOSCO Asia-Pacific Meet-up Sets Roadmap For Sustainable And Secure Capital Markets
The Securities and Futures Commission (SFC) recently participated in a series of dialogues under the International Orga... Read more
WeLab Bank Accelerates AI Deployment With Deepseek To Enhance Efficiency
WeLab Bank has taken a significant step forward in its AI deployment strategy by exploring innovative solutions to enha... Read more
Fusion Bank Completes Core Banking System Migration In 10 Months With Tencent Cloud
Fusion Bank, a licensed digital bank in Hong Kong, has completed its migration to a new core banking system in collabor... Read more
Hong Kong Banks Can Begin Issuing Credit Cards In Mainland China From March 1
Hong Kong banks’ mainland credit cards will soon be available in mainland China, marking a significant step towards d... Read more
SFC Introduces ASPIRe Roadmap To Strengthen Virtual Asset Market In Hong Kong
The Securities and Futures Commission (SFC) outlined 12 key initiatives under the SFC virtual asset ASPIRe roadmap to e... Read more